Article in Obstetrics and gynecology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Rodrigo Aldariz-AmayaUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0002-0313-5109
Alfonso Ruiz-RomeroUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0002-5233-813X
Fernanda AnthorUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0009-0003-1662-2031
Emmanuel MaresUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0009-0006-1978-4994
Angélica Flores-MartínezDivisión de Ginecología, Hospital de la Mujer, Secretaria de Salud, Mexico City, Mexico.
Edgar Alejandro Gómez-VillaDivisión de Ginecología, Hospital de la Mujer, Secretaria de Salud, Mexico City, Mexico.
Marco Antonio Fuentes-GarciaUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0001-7553-5737
Teresa Apresa-GarcíaUnidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, Centro Médico Nacional Siglo XXI-IMSS, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-0312-3087
Ricardo López-RomeroUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0002-5030-5836
Emmanuel SalcedoUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0001-5600-4869
Mauricio SalcedoUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.ORCID https://orcid.org/0000-0002-9978-6511
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection. · full record | OpenQuestion